A Study of TIX100 for Healthy Overweight/Obese Adults
This study is looking at a new oral medication called TIX100. We want to see how safe TIX100 is and how well your body handles it (tolerability) when taken daily for 28 days. Some participants will receive TIX100, while others will receive a placebo (an inactive substance). We are looking for healthy adults between 18 and 70 years old who are overweight or have obesity. The main goal is to understand the safety and tolerability of TIX100 over 35 days. The study aims to enroll 18 participants, but the current recruitment status is unclear.
- Study design
- This is a randomized, placebo-controlled study involving 18 participants. It is designed to compare TIX100 to a placebo.
- What's involved
- You would take either TIX100 or a placebo by mouth daily for 28 days. Your safety and tolerability will be monitored from Day 1 to Day 35.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your safety and tolerability will be monitored for 7 days after the last dose, up to Day 35.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Anath Shalev, MD · PRINCIPAL_INVESTIGATOR · TIXiMED, Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Safety and TolerabilityDay 1 to Day 35
* Number of subjects with Treatment-Emergent Adverse Events (TEAEs) * Number of subjects with clinically significant TEAEs (Physical Examination, Vital Signs, ECG)